logo

For the Inventor, By the Inventor

Lainate, Italy

Cassiopea S.p.a.

Calculating rank
USPTO Granted Patents = 14



Trademarks = 4

Forward Citations = 43

Loading Chart...
Loading Chart...

3 inventors (with patents filed for the assignee):

goldMedal Luigi Moro (10 out of 32 patents)

silverMedal Mauro Ajani (10 out of 44 patents)

bronzeMedal Luigi Maria Longo (4 out of 16 patents)

4.  Michael Albeck (36 patents)

5.  Benjamin Sredni (32 patents)


14 patents:

1. 12337002 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2025-06-24),
2. 11938141 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2024-03-26),
3. 11883415 - High concentration formulation (2024-01-30),
4. 11213531 - High concentration formulation (2022-01-04),
5. 11207332 - Enzymatic process for obtaining 17 α-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2021-12-28),
6. 10980819 - High concentration formulation (2021-04-20),
7. 10716796 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2020-07-21),
8. 10603327 - High concentration formulation (2020-03-31),
9. 10166245 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2019-01-01),
10. 10159682 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2018-12-25),
11. 9895379 - 17alpha, 21-dihydroxypregnene esters as antiandrogenic agents (2018-02-20),
12. 9486458 - Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2016-11-08),
13. 9433628 - Enzymatic process for obtaining 17α-monoesters of cortexolone and/or its 9,11-dehydroderivatives (2016-09-06),
14. 9211295 - 17 alpha, 21-dihydroxypregnene esters as antiandrogenic agents (2015-12-15),
Company Overview
Cassiopea S.p.a. is an innovative biopharmaceutical company based in Lainate, Italy, focused on developing and commercializing novel dermatological therapies. The company specializes in research and development of treatments for skin conditions, leveraging advanced technologies to address unmet medical needs. With a commitment to scientific excellence, Cassiopea aims to enhance patient outcomes through its proprietary formulations and clinical expertise, positioning itself as a key player in the global dermatology market.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

14 Patents

#3 in Lainate

#664 in Italy

#42,312 in the World

Lainate, IT
Lainate, Italy

Cassiopea S.p.a.

Forward Citations = 43

3 inventors:

goldMedal Luigi Moro (10 out of 32 patents)

silverMedal Mauro Ajani (10 out of 44 patents)

bronzeMedal Luigi Maria Longo (4 out of 16 patents)

4.  Michael Albeck (36 patents)

5.  Benjamin Sredni (32 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cassiopea S.p.a.. Retrieved from https://idiyas.com/company/cassiopea

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…